CLL Pharma Overview

  • Founded
  • 1995
Founded
  • Status
  • Out of Business
  • Employees
  • 11
Employees
  • Latest Deal Type
  • Liquidation

CLL Pharma General Information

Description

Developer of generic drugs designed to offer galenical formulations. The company's products include formulations that helps in developing medicines for better treatment acceptance and compliance, enabling healthcare professionals to offer advanced treatment to their patients.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
  • Nice Premier - Arénas
  • 455, Promenade des Anglais
  • 06299 Nice
  • France
+33 04 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CLL Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Bankruptcy: Liquidation 17-May-2017 Completed Bankruptcy: Liquidation
3. Merger/Acquisition 02-Jun-2003 Completed Generating Revenue
2. Secondary Transaction - Private Completed Startup
1. Early Stage VC Completed Startup
To view CLL Pharma’s complete valuation and funding history, request access »

CLL Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of generic drugs designed to offer galenical formulations. The company's products include formulations that he
Drug Discovery
Nice, France
11 As of 2016
000000000000

00000000

ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in
0000000000000
Montreal, Canada
0000 As of 0000
00000000000

000 0000

n reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occae
000000000000000
Milan, Italy
00 As of 0000
0.000 0000-00-00
000000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CLL Pharma Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pharmascience Corporation Montreal, Canada 0000 00000000000
000 00000000 Private Equity-Backed Milan, Italy 00 000000000000
You’re viewing 2 of 2 competitors. Get the full list »

CLL Pharma Executive Team (4)

Name Title Board Seat Contact Info
Claude Laruelle Ph.D Chairman and Chief Executive Officer
Thierry Breul Director, Research & Development
Stephane Laruelle Executive Director
You’re viewing 3 of 4 executive team members. Get the full list »

CLL Pharma Board Members (1)

Name Representing Role Since
Claude Laruelle Ph.D CLL Pharma Chairman and Chief Executive Officer 000 0000
To view CLL Pharma’s complete board members history, request access »

CLL Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CLL Pharma Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000:00 01-Jan-2005 000000000000000000 Drug Discovery
To view CLL Pharma’s complete acquisitions history, request access »